Digitisation | December 22, 2023
Digital transformation key to managing rising organisational healthcare costs in India
Employer-sponsored health insurance costs in India are expected to rise by 11% in 2024
Employer-sponsored health insurance costs in India are expected to rise by 11% in 2024
Development services for gene and cell therapies is planned to begin first in 2025
V116 is an investigational, 21-valent pneumococcal conjugate vaccine specifically designed to protect adults
KBR will provide outreach, education and data analytics to support critical neuroscience research for the prevention and treatment of military members with CTE
The bioprocess business will continue to pioneer contributions to safety and productivity in the manufacture of biotherapeutics
Studies have demonstrated that ZYIL1 is highly potent and can suppress inflammation caused by NLRP3 inflammasome activation
Sitagliptin Tablets USP, 25 mg, 50 mg, and 100 mg are indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus
Lacosamide is indicated to treat partial-onset seizures
Fischer Chemic will make an entry into the growing market of diagnostic imaging industry with innovative and disruptive technologies
The product will be manufactured at Lupin's Pithampur facility in India
Subscribe To Our Newsletter & Stay Updated
